Thomas is a proven aerosol and inhaler expert, combining scientific, regulatory, market and strategic expertise. He joins Actarmo from Sandoz International.

He was heading several projects for different scopes. His experience expands from CMC and clinical to regulatory and market. He was setting up development and regulatory strategy and participated regularly in meetings with authorities. Thomas evaluated major projects from technical feasibility and commercial viability through to endorsement process and execution.

Thomas laid the ground for his international career during his 8 years at Aeropharm (Sandoz), where he served as project manager for generic dry powder and metered dose inhalers. During this time, Thomas set-up the dry powder inhaler department (development, analytical and manufacturing) and was leading the team to approval of a major product (Airflusal®).

Before his career at Sandoz, Thomas spent several years at Pulmotec and Sofotec where he was involved in different DPI development programs.

Carsten serves as the Head of Quality Control at Actarmo Medical, having joined the company in 2022 as a Senior Project Manager and CMC Expert. In this role, he is responsible for managing both internal and external projects, acting as the primary contact for clients. He assumed the role of Head of Quality Control in May 2025, where he and his team oversee the successful implementation and validation of analytical methods for upcoming investigations.

A chemist by training, Carsten holds a PhD in environmental chemistry and ecotoxicology, boasting over 20 years of experience in the pharmaceutical industry. Prior to his tenure at Actarmo Medical, he worked as a Senior Project Manager at Leon Nanodrugs, a company specializing in the development of nanoformulations. Carsten began his career in the pharmaceutical sector in 2001 at Hexal/Sandoz, where he held positions as group head and project manager in analytical development.

Carsten possesses extensive analytical expertise across various dosage forms, including solid oral dosage forms, solutions, suspensions, liposomal formulations, transdermal delivery systems, and parenteral products. He has been responsible for method validations, transferring analytical methods to global production and testing sites, and conducting stability studies in accordance with ICH guidelines across diverse scopes. Carsten has collaborated with global project teams, engaging with members from China, Brazil, India, the US, and other countries. Additionally, he has supported the Business Development team in Due Diligence processes for complex projects, focusing on the analytical components.

Knut is a renowned aerosol scientist with more than 20 years of experience. During his professional career, Knut dealt with all aspects of aerosol generation and analysis and their behavior in the respiratory tract. In this scientific area, he co-authored more than 40 peer reviewed scientific articles.

He came in contact with all types of inhalation drug products: Dry Powder Inhalers (DPI), pressurized Metered Dose Inhalers (pMDI), Soft Mist Inhalers and Nebulizers (Jet, Mesh and Ultrasonic Nebulizer) and gained vast knowledge in the analytical methods to characterize these products.

In his last position as Senior Director in-vitro trials and Head of Manufacturing at Inamed, he successfully implemented a GMP system for manufacturing of radio labelled IMPs for lung deposition studies and gained the manufacturing authorization for radio labelling of several inhalation drug products.